113 related articles for article (PubMed ID: 15716639)
1. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
Strauss SM; Astone JM; Des Jarlais DC; Hagan H
AIDS Patient Care STDS; 2005 Feb; 19(2):78-88. PubMed ID: 15716639
[TBL] [Abstract][Full Text] [Related]
2. Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.
Vassilev ZP; Strauss SM; Astone J; Des Jarlais DC
J Behav Health Serv Res; 2004; 31(2):208-16. PubMed ID: 15255228
[TBL] [Abstract][Full Text] [Related]
3. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
Kresina TF; Bruce RD; Cargill VA; Cheever LW
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
[TBL] [Abstract][Full Text] [Related]
4. Provision of hepatitis C education in a nationwide sample of drug treatment programs.
Astone J; Strauss SM; Vassilev ZP; Des Jarlais DC
J Drug Educ; 2003; 33(1):107-17. PubMed ID: 12773028
[TBL] [Abstract][Full Text] [Related]
5. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
6. Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
Strauss SM; Rindskopf DM; Astone-Twerell JM; Des Jarlais DC; Hagan H
Drug Alcohol Depend; 2006 Jun; 83(1):15-24. PubMed ID: 16289523
[TBL] [Abstract][Full Text] [Related]
7. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
8. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia.
Winstock AR; Anderson CM; Sheridan J
Med J Aust; 2006 Jun; 184(11):560-2. PubMed ID: 16768662
[TBL] [Abstract][Full Text] [Related]
9. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
[TBL] [Abstract][Full Text] [Related]
10. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
Strauss SM; Astone JM; Jarlais DD; Hagan H
Drug Alcohol Depend; 2004 Mar; 73(3):227-36. PubMed ID: 15036545
[TBL] [Abstract][Full Text] [Related]
11. Gaps in the drug-free and methadone treatment program response to Hepatitis C.
Strauss SM; Astone J; Vassilev ZP; Des Jarlais DC; Hagan H
J Subst Abuse Treat; 2003 Jun; 24(4):291-7. PubMed ID: 12867202
[TBL] [Abstract][Full Text] [Related]
12. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
13. Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.
Strauss SM; Astone-Twerell J; Munoz-Plaza CE; Des Jarlais DC; Gwadz M; Hagan H; Osborne A; Rosenblum A
BMC Health Serv Res; 2007 Mar; 7():39. PubMed ID: 17346346
[TBL] [Abstract][Full Text] [Related]
14. A nationwide survey of hepatitis C services provided by drug treatment programs.
Strauss SM; Falkin GP; Vassilev Z; Des Jarlais DC; Astone J
J Subst Abuse Treat; 2002 Mar; 22(2):55-62. PubMed ID: 11932130
[TBL] [Abstract][Full Text] [Related]
15. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.
Strauss SM; Astone JM; Hagan H; Des Jarlais DC
J Urban Health; 2004 Mar; 81(1):38-47. PubMed ID: 15047782
[TBL] [Abstract][Full Text] [Related]
16. Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.
Frimpong JA; D'Aunno T; Helleringer S; Metsch LR
BMC Public Health; 2016 Jul; 16():666. PubMed ID: 27473519
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C prevention programs: assessment of local health department capacity.
Fraser MR; Buffington J; Lipson L; Meit M
J Public Health Manag Pract; 2002 Mar; 8(2):46-9. PubMed ID: 11889851
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
19. Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
Astone JM; Strauss SM; Hagan H; Des Jarlais DC
Am J Drug Alcohol Abuse; 2004 Nov; 30(4):783-97. PubMed ID: 15624549
[TBL] [Abstract][Full Text] [Related]
20. [Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users].
Gyarmathy VA; Rácz J
Orv Hetil; 2011 Jan; 152(4):124-30. PubMed ID: 21224188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
